NEXT NEWS why is Nextdecade Corporation price falling or rising
NEXT NEWS reasons for why stock price of Nextdecade Corporation is falling or rising
NEXT Nextdecade Corporation is falling or rising technical reasons
Technical analysis forecast of Nextdecade Corporation Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Nextdecade Corporation NEXT at this time. Stock is rising and might rise more.
It appears as if Nextdecade Corporation NEXT gave a large move recently.
Stock of Nextdecade Corporation (NEXT) is trading above an important moving average line, but it crossed this line recently, which means that it could show a small or a large fall soon enough depending on its trend.
My analysis of Nextdecade Corporation is bullish for shortterm, and stock might move up till 7.8 or till 8.3. Use a stoploss of 7.32 and if this stock hits its stoploss, then it can fall down till 6.86
NEXT Nextdecade Corporation is falling or rising NEWS fundamental reasons
Indian market faces AI narrative problem; it'll be smallcaps over largecaps for next 5 years: Manish Gunwani Indian stock market valuations are attractive. However, global investor focus on Artificial Intelligence is diverting capital away from emerging markets like India. Foreign institutional investor flows are expected to remain subdued unless the AI theme slo - NEWS as on 2026-04-20 indiatimes.com
Aavas Financiers may be headed for leadership change; Kotak's Manu Singh likely to be Next CEO Aavas Financiers is set for a leadership change. Managing Director Sachinder Bhinder will step down following promoter dissatisfaction. Manu Singh, currently heading home loans at Kotak Mahindra Bank, is expected to become the new CEO. This transition foll - NEWS as on 2026-04-13 indiatimes.com
Russell 2000 Tracking for New Highs: What’s Next for ETF Traders? The Russell 2000 is a critically important index that tracks the leading 2,000 small-cap stocks on U.S.-listed markets. Arguably the riskiest stocks, those belonging to the Russell 2000 tend to perform best when economic conditions are at their prime. And - NEWS as on 2026-04-12 nasdaq.com
TABP expects Rs 800 crore revenue over the next three years TABP aims to nearly quadruple revenue to Rs 800 crore in three years. The company is focusing on mass-market consumers with Rs10 priced beverages. It will leverage hyper-local flavors and a strong distribution network. TABP plans to build multiple Rs 300-4 - NEWS as on 2026-04-10 indiatimes.com
The Next Stage of the AI Boom After more than half a year of languishing, the AI Boom appears ready to reassert its leadership. - NEWS as on 2026-04-09 nasdaq.com
billion! Dalal Street braces for 81 IPO lock-in expiries in next 3 months. Check details A wave of IPO lock-in expiries is set to hit Dalal Street, with 81 companies unlocking nearly billion worth of shares over the next three months, though large-scale selling may be limited as promoters are likely to retain holdings. - NEWS as on 2026-04-09 indiatimes.com
‘Many’ at Fed expect next rate move to be cut, with ‘some’ open to hike: minutes - NEWS as on 2026-04-08 marketwatch.com
LIC share price jumps 8%. Will PSU issue bonus shares next week? LIC Bonus Share: Shares of Life Insurance Corporation of India surged over 8% after the PSU giant said its board will meet on April 13 to consider its first-ever bonus issue. The rally comes amid broader market optimism, with the Sensex and Nifty 50 jumpin - NEWS as on 2026-04-08 indiatimes.com
Silver drags commodity ETFs down up to 15% in March. What next for investors? Commodity ETFs declined up to 15% in March, led by sharp losses in silver ETFs amid rising oil prices, geopolitical tensions and tightening liquidity. Gold ETFs also fell as stronger dollar dynamics weighed on prices. The outlook now hinges on inflation tr - NEWS as on 2026-04-04 indiatimes.com
Lilly's weight-loss pill wins US approval, sets up next battle with rival Novo Nordisk The US FDA has approved Eli Lilly's new weight-loss pill, Foundayo. This marks a significant step in the ongoing competition with rival Novo Nordisk in the GLP-1 medicine market. Foundayo is an oral medication offering a new option for weight management. L - NEWS as on 2026-04-02 indiatimes.com
More announcements and NEWS
NEXT Nextdecade Corporation current price & indicator signals
Recent prices of NEXT Nextdecade Corporation are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 21 Tue Apr 2026 | 7.51 | 7.08 to 7.57 | 5.03% | 0.7 times |
| 20 Mon Apr 2026 | 7.15 | 6.85 to 7.38 | 4.53% | 0.76 times |
| 17 Fri Apr 2026 | 6.84 | 6.76 to 7.32 | -9.28% | 1.38 times |
| 16 Thu Apr 2026 | 7.54 | 7.04 to 7.55 | 5.31% | 0.71 times |
| 15 Wed Apr 2026 | 7.16 | 7.16 to 7.42 | -3.37% | 0.66 times |
| 14 Tue Apr 2026 | 7.41 | 7.32 to 7.64 | -1.59% | 0.66 times |
| 13 Mon Apr 2026 | 7.53 | 7.43 to 7.87 | -0.13% | 0.81 times |
| 10 Fri Apr 2026 | 7.54 | 7.16 to 7.66 | 2.45% | 0.65 times |
| 09 Thu Apr 2026 | 7.36 | 7.34 to 8.35 | -8.91% | 1.03 times |
| 08 Wed Apr 2026 | 8.08 | 7.30 to 8.25 | -7.55% | 1.67 times |
| 07 Tue Apr 2026 | 8.74 | 8.36 to 9.06 | 5.3% | 1.67 times |
| 06 Mon Apr 2026 | 8.30 | 7.70 to 8.41 | 5.87% | 0.84 times |
Videos related to: NEXT NEWS why is Nextdecade Corporation price falling or rising
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
Hindi Basics How To Trade In FnO Futures Options Stock Market
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


